Skip to content
10-Q

Quarterly Report

PLANDAI BIOTECHNOLOGY, INC.

0001262463-15-000391

← back to feed
Filed
May 20, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · May 20, 2015 160.52M sh
Long Term Debt Q3 2015 · Mar 31, 2015 $5.67M
Long Term Debt Q3 2015 · Jun 30, 2014 $11.64M
Short Term Debt Q3 2015 · Mar 31, 2015 $7.95M
Stockholders Equity Q3 2015 · Mar 31, 2015 −$4.28M
Stockholders Equity Q3 2015 · Jun 30, 2014 −$2.2M
Current Liabilities Q3 2015 · Mar 31, 2015 $8.36M
Current Liabilities Q3 2015 · Jun 30, 2014 $226.9K
Total Liabilities Q3 2015 · Mar 31, 2015 $15.71M
Total Liabilities Q3 2015 · Jun 30, 2014 $13.22M
Current Assets Q3 2015 · Mar 31, 2015 $273.45K
Current Assets Q3 2015 · Jun 30, 2014 $593.66K
Total Assets Q3 2015 · Mar 31, 2015 $9.9M
Total Assets Q3 2015 · Jun 30, 2014 $9.68M
Gross Profit Q3 2015 · Mar 31, 2015 −$159.47K
Gross Profit Q3 2015 · Mar 31, 2015 −$519.48K
Gross Profit Q3 2015 · Mar 31, 2014 −$128.49K
Gross Profit Q3 2015 · Mar 31, 2014 −$232.82K
Cost Of Revenue Q3 2015 · Mar 31, 2015 $181.21K
Cost Of Revenue Q3 2015 · Mar 31, 2015 $583.51K
Cost Of Revenue Q3 2015 · Mar 31, 2014 $141.05K
Cost Of Revenue Q3 2015 · Mar 31, 2014 $483.68K
Capex Q3 2015 · Mar 31, 2014 $1.11M
Operating Cash Flow Q3 2015 · Mar 31, 2014 −$1.83M
Cash And Equivalents Q3 2015 · Mar 31, 2014 $626.08K
Cash And Equivalents Q3 2015 · Jun 30, 2013 $498.92K
Sga Expense restated Q3 2015 · Mar 31, 2014 $121.98K
Sga Expense restated Q3 2015 · Mar 31, 2014 $130.07K
Rd Expense Q3 2015 · Mar 31, 2014 $83.23K
Net Income Q3 2015 · Mar 31, 2014 −$3.05M
Net Income Q3 2015 · Mar 31, 2014 −$7.1M
Operating Income Q3 2015 · Mar 31, 2014 −$2.9M
Operating Income Q3 2015 · Mar 31, 2014 −$4.64M
Revenue Q3 2015 · Mar 31, 2014 $12.55K
Revenue Q3 2015 · Mar 31, 2014 $250.86K